A Molecular Link Between the Active Component of Cannabis and Alzheimer’s Disease Pathology

Medical Cannabis and Alzheimer's Disease

As reported in a 2006 issue of Molecular Pharmacology: “Compared to currently approved drugs prescribed for the treatment of Alzheimer’s disease, THC is a considerably superior inhibitor of Aβ aggregation, and this study provides a previously unrecognized molecular mechanism through which cannabinoid molecules may directly impact the progression of this debilitating disease.”

A Molecular Link Between the Active Component of Cannabis and Alzheimer’s Disease Pathology